Creo Medical Group plc logo

Creo Medical Group plc (CREO)

Market Closed
13 Feb, 00:00
LSE LSE
£
16. 75
0
0%
£
69.23M Market Cap
- P/E Ratio
- Div Yield
319,565 Volume
- Eps
£ 16.75
Previous Close
Add Transaction
Day Range
16.5 17
Year Range
9.22 20
Want to track CREO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CREO closed Friday higher at £16.75, an increase of 0% from Thursday's close, completing a monthly increase of 0% or £16.75. Over the past 12 months, CREO stock gained 0%.
CREO is not paying dividends to its shareholders.
The last earnings report, released on Sep 10, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

CREO Chart

People also search for

Digia Oyj
5.95
-1.8152%
Scancell Holdings PLC
£ 13.25
0%
EKF
EKF Diagnostics Holdings PLC
£ 25.8
+7.5%
Faron Pharmaceuticals Oy
£ 162.5
-1.5152%
Nanobiotix S.A.
32.78
-1.0266%

Creo Medical Group plc (CREO) FAQ

What is the stock price today?

The current price is £16.75.

On which exchange is it traded?

Creo Medical Group plc is listed on LSE.

What is its stock symbol?

The ticker symbol is CREO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 69.23M.

Has Creo Medical Group plc ever had a stock split?

No, there has never been a stock split.

Creo Medical Group plc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Craig Jonathan Gulliford CEO
LSE Exchange
G253HH102 CUSIP
GB Country
104 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Creo Medical Group PLC, founded in 2003 and headquartered in Chepstow, the United Kingdom, operates as a pioneering entity within the medical devices sector. The company is engaged in the rigorous research, development, manufacture, and sales of advanced medical devices and instruments, catering primarily to the UK market. At the heart of Creo Medical Group's innovation is the development of CROMA, an avant-garde energy platform that adeptly combines bipolar radiofrequency with microwave energy. This combination not only facilitates precise and localized cutting but also ensures controlled coagulation. The primary objective of this technology is to equip physicians with tools that are both highly controllable and accurate, delivered through the convenience of a flexible endoscope.

Products and Services

  • Speedboat Inject

    An innovative energy multimodal instrument designed for flexible endoscopy, offering a blend of precision and versatility in treatment applications.

  • MicroBlate Fine

    A microwave needle ablation device, introducing an efficient solution for the focused ablation of soft tissues with minimal invasiveness.

  • MicroBlate Flex

    A flexible microwave ablation device tailored for the effective ablation of soft tissues, enhancing procedural flexibility and patient outcomes.

  • SlypSeal Flex

    A flexible haemostasis device specifically designed to address the challenges of treating upper and lower gastrointestinal (GI) bleeds, marking a significant advancement in GI care.

  • SpydrBlade Flex

    A unique flexible bipolar RF and microwave scissor device engineered for the precise grasping, cutting, and coagulation of highly perfused tissues, setting new standards in surgical precision.

  • Endotherapy Accessories
    • ScopeSnare: An energy-based polypectomy snares, enhancing the efficiency and safety of polypectomy procedures.
    • ScopeSnare Cold: A cutting wire designed for the safe and effective removal of diminutive, sessile, and pedunculated polyps and tissue within the GI tract, leveraging cold-cutting technology.
    • ScopeClip: A single-use rotational and repositionable hemoclips, introducing a new level of precision in the management of gastrointestinal bleeding.
    • ScopeBite: A portfolio of biopsy forceps, designed to enhance the accuracy and effectiveness of biopsy procedures.
    • ScopeGrasp: A series of grasping forceps, engineered to provide unsurpassed control and efficiency in tissue manipulation during endoscopic procedures.
    • ScopeInject: An injection needle created to facilitate high precision during endoscopic injection procedures, ensuring maximum effectiveness and patient safety.

Contact Information

Address: Creo House, Chepstow, United Kingdom, NP16 5UH
Phone: 44 12 9160 6005